PHAXIAM Therapeutics S.A. (0QSS.L) LSE

0.10

+0.0065(+6.91%)

Updated at September 02 03:24PM

Currency In EUR

Valuation

Market Cap20.24M
Enterprise Value23.03M
P/E Ratio-0.06
PEG Ratio-0
Price/Sales Ratio0.92
Price/Book Ratio0.04
Enterprise/Revenue9.53
Enterprise/EBITDA-0.99

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterJune 30, 2024

Profitability

Profit Margin-9.73
Operating Margin-9.75

Management Effectiveness

Return On Assets-0.27
Return On Equity-0.52

Income Statement

Revenue1.33M
Revenue/Share0.18
Gross Profit1.33M
EBITDA-22.93M
Net Income-23.49M
Diluted EPS-5

Balance Sheet

Total Cash1.46M
Total Cash/Share0.24
Total Debt10.87M
Total Debt/Equity0.7
Current Ratio0.38
Book Value Per Share2.54

Price History

52-Week Change-93.98
52-Week High11.02
52-Week Low0.1
Moving Average 50 Days4.35
Moving Average 200 Days5.62

Statistics

Average Volume21
Shares Outstanding10.05M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor66:61
Last Split DateJune 14, 2024